1 / 8

Over the Counter (OTC) Drugs & Dietary Supplements Market

Global Over The Counter (OTC) Drugs & Dietary Supplements Market was valued at $223 billion in 2016, and is expected to reach $335 billion by 2023, registering a CAGR of 5.9% from 2017 to 2023. OTC drugs are also known as non-prescription medicines, as these can be availed without prescriptions. OTC medicines are safe if they are administered according to the instructions provided by healthcare professionals. However, dietary supplements contain dietary ingredients, which are used to provide nutrients to the body to fulfill the nutrient balance of the body. In addition, they provide non-nutrient chemicals, which provide biological benefit to the body.

swati_tamhankar
Télécharger la présentation

Over the Counter (OTC) Drugs & Dietary Supplements Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Over the Counter (OTC) Drugs & Dietary Supplements Market  Global Opportunity Analysis and Industry Forecast, 2017-2023

  2. Overview: .  Global Over The Counter (OTC) Drugs & Dietary Supplements Market was valued at $223 billion in 2016, and is expected to reach $335 billion by 2023, registering a CAGR of 5.9% from 2017 to 2023.  OTC drugs are also known as non-prescription medicines, as these can be availed without prescriptions. OTC medicines are safe if they are administered according to the instructions provided by healthcare professionals. However, dietary supplements contain dietary ingredients, which are used to provide nutrients to the body to fulfill the nutrient balance of the body. In addition, they provide non-nutrient chemicals, which provide biological benefit to the body. Development of strong regulatory policies governing the sale of OTC drugs and the focus of manufacturers to adhere to higher quality standard and correct branding and labeling of dietary supplements have intensified their interest in the marketing of these products. All these factors are anticipated to give impetus to the market across the globe

  3. The research report is prepared with extensive inputs from a wide range of market participants that include business executives, product managers, clinical specialists, healthcare organizations, and leading trade associations. The report provides in-depth analysis of the current and emerging trends, key drivers and restraining factors, changes in regulatory landscape and their impact on competitive dynamics, and strategies adopted by the leading market players. • Key Benefits • The study provides an in-depth analysis of the global over the counter (OTC) drugs & dietary supplements market along with the current trends and future estimations to elucidate the imminent investment pockets. • A quantitative analysis from 2016 to 2023 is discussed to enable stakeholders to capitalize on the prevailing market opportunities. • Key market players are profiled and their strategies are thoroughly analyzed to understand the competitive outlook of the industry. • Porters five forces model is expected to interpret the impact of bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players on the market growth.

  4. Over the counter (OTC) drugs are non-prescription medicines, which are sold directly to consumers without any prescription from doctors and other healthcare professionals. The OTC drugs are regulated by governmental bodies to ensure that the ingredients used are safe and effective for use without a physician's supervision. • These drugs are regulated by active pharmaceutical ingredients (APIs) not final product. Dietary supplements are intended to provide nutrients to increase the quantity of consumption or provide non-nutrient chemicals that have biologically beneficial effects to users. • These supplements are available across all distribution channels such as pharmacies, grocery stores, shopping marts, online pharmacies, and other retailers. The global over the counter (OTC) drugs & dietary supplements market was valued at $223 billion in 2016, and is expected to reach at $335 billion by 2023, registering a CAGR of 5.9% from 2017 to 2023.

  5. Segmentation By Category Vitamin & Dietary SupplementsCough & Cold ProductsAnalgesicsGastrointestinal ProductsSleep AidsOtic ProductsWart RemoversMouth Care ProductsOphthalmic ProductsBotanicalsAntacidsSmoking Cessation ProductsFeminine CareOthers By Dosage Form TabletsHard CapsulesPowdersOintmentsSoft CapsulesLiquidsOthers By Distribution ChannelPharmaciesGrocery StoresVitamin & Health Food StoresOnline PharmacyOthers By ProductBranded DrugsGeneric Drugs

  6. BY GEOGRAPHY NORTH AMERICA EUROPE LAMEA ASIA-PACIFIC

  7. The report provides a comprehensive analysis of the key players operating in the global market such as Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc., Bayer Healthcare AG, AstraZeneca plc. Download the full report: https://www.alliedmarketresearch.com/request-sample/2695

  8. Thank You! For More Details Visit us at https://www.alliedmarketresearch.com

More Related